Exploiting Genomic and Metagenomic Determinants of the Metabolome in Non-Alcoholic Fatty Liver Disease for Precision Medicine
Furthering work from the FLORINASH study, to determine how the microbiome directly affects NAFLD phenotypes (i.e. steatosis, inflammation, liver enzymes) independently of other risk factors.